See more : DistIT AB (publ) (DIST.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Middle East Healthcare Company (4009.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Middle East Healthcare Company, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Live Verdure Ltd (LV1.AX) Income Statement Analysis – Financial Results
- Brera Holdings PLC Class B Ordinary Shares (BREA) Income Statement Analysis – Financial Results
- Search Minerals Inc. (SMY.V) Income Statement Analysis – Financial Results
- Tai Cheung Holdings Limited (0088.HK) Income Statement Analysis – Financial Results
- Investco Corporation (IVCO) Income Statement Analysis – Financial Results
Middle East Healthcare Company (4009.SR)
About Middle East Healthcare Company
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. The company operates multi-specialty tertiary level hospitals, which comprise Saudi German HospitalJeddah with 218 beds; Saudi German Hospital-Aseer with 400 beds; Saudi German Hospital-Riyadh with 300 beds; Saudi German Hospital-Madinah with 300 beds; and Saudi German Hospital-Hail with 150 beds. Its multi-specialty tertiary care hospitals also include Saudi German Hospital-Dammam with 150 to 300 beds; Saudi German Hospital-Sanaa with 300 beds; Saudi German HospitalDubai with 300 beds; Saudi German HospitalSharjah with 50 beds; Saudi German HospitalAjman with 100-200 beds; and Saudi German Hospital-Cairo with 332 beds. The company was founded in 1988 and is based in Jeddah, the Kingdom of Saudi Arabia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.65B | 2.15B | 1.87B | 1.77B | 1.50B | 1.39B | 1.63B | 1.62B | 1.53B | 1.40B | 828.36M | 542.22M |
| Cost of Revenue | 1.65B | 1.47B | 1.26B | 1.17B | 1.02B | 889.94M | 864.52M | 787.92M | 724.39M | 655.37M | 401.21M | 295.30M |
| Gross Profit | 1.00B | 680.01M | 608.18M | 600.00M | 472.93M | 500.75M | 764.91M | 827.72M | 810.13M | 743.39M | 427.15M | 246.93M |
| Gross Profit Ratio | 37.83% | 31.60% | 32.48% | 33.86% | 31.60% | 36.01% | 46.94% | 51.23% | 52.79% | 53.15% | 51.57% | 45.54% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 610.16M | 83.97M | 102.41M | 87.51M | 53.97M | 315.62M | 82.07M | 283.58M | 261.60M | 233.57M | 138.32M | 88.99M |
| Selling & Marketing | 51.08M | 30.38M | 45.97M | 31.14M | 14.78M | 10.17M | 11.91M | 181.31M | 162.35M | 189.95M | 146.98M | 84.83M |
| SG&A | 661.23M | 114.35M | 148.38M | 118.65M | 68.75M | 324.14M | 93.98M | 464.89M | 423.95M | 423.52M | 285.30M | 173.82M |
| Other Expenses | 0.00 | 420.81M | 397.20M | 351.61M | 298.99M | -338.02M | 15.06M | -7.24M | -8.25M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 661.23M | 535.16M | 545.58M | 470.27M | 367.74M | -338.02M | 488.20M | 457.64M | 415.70M | 407.05M | 285.88M | 175.73M |
| Cost & Expenses | 2.31B | 2.01B | 1.81B | 1.64B | 1.39B | 889.94M | 1.35B | 1.25B | 1.14B | 1.06B | 687.10M | 471.03M |
| Interest Income | 6.63M | 65.99M | 41.52M | 31.11M | 20.02M | 0.00 | 0.00 | 0.00 | 0.00 | 4.13M | 1.14M | 0.00 |
| Interest Expense | 159.81M | 65.99M | 41.52M | 31.11M | 20.02M | 11.11M | 12.00M | 11.33M | 4.47M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 189.81M | 145.97M | 141.41M | 127.22M | 98.41M | 88.95M | 76.72M | 63.59M | 52.30M | 44.55M | 34.25M | 34.94M |
| EBITDA | 551.24M | 297.41M | 212.90M | 243.83M | 220.73M | 251.68M | 387.89M | 421.96M | 446.73M | 357.72M | 184.20M | 100.37M |
| EBITDA Ratio | 20.78% | 13.72% | 10.89% | 14.65% | 14.27% | 13.07% | 22.53% | 26.53% | 29.11% | 25.57% | 19.67% | 18.51% |
| Operating Income | 342.50M | 140.34M | 54.24M | 126.40M | 103.27M | 162.73M | 275.37M | 370.08M | 394.44M | 313.18M | 128.70M | 65.44M |
| Operating Income Ratio | 12.91% | 6.52% | 2.90% | 7.13% | 6.90% | 11.70% | 16.90% | 22.91% | 25.70% | 22.39% | 15.54% | 12.07% |
| Total Other Income/Expenses | -140.88M | -59.12M | -35.01M | -26.73M | -7.98M | 7.94M | 3.06M | 5.09M | -4.47M | 12.35M | 11.22M | 5.76M |
| Income Before Tax | 201.62M | 81.22M | 19.23M | 99.68M | 95.28M | 170.67M | 278.43M | 358.75M | 389.97M | 332.21M | 140.12M | 71.20M |
| Income Before Tax Ratio | 7.60% | 3.77% | 1.03% | 5.62% | 6.37% | 12.27% | 17.09% | 22.21% | 25.41% | 23.75% | 16.92% | 13.13% |
| Income Tax Expense | 17.98M | 9.62M | 7.50M | 5.50M | 5.18M | 6.10M | 5.47M | 47.86K | 2.12K | 584.89K | 3.53M | 2.50M |
| Net Income | 180.18M | 75.18M | 11.73M | 81.99M | 97.57M | 172.25M | 300.08M | 361.86M | 390.25M | 331.97M | 137.20M | 61.99M |
| Net Income Ratio | 6.79% | 3.49% | 0.63% | 4.63% | 6.52% | 12.39% | 18.42% | 22.40% | 25.43% | 23.73% | 16.56% | 11.43% |
| EPS | 1.96 | 0.82 | 0.13 | 0.89 | 1.06 | 1.87 | 3.47 | 3.94 | 4.24 | 3.61 | 1.49 | 0.67 |
| EPS Diluted | 1.96 | 0.82 | 0.13 | 0.89 | 1.06 | 1.87 | 3.47 | 3.94 | 4.24 | 3.61 | 1.49 | 0.67 |
| Weighted Avg Shares Out | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 91.96M | 92.08M | 92.53M |
| Weighted Avg Shares Out (Dil) | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 92.04M | 92.07M | 92.04M | 92.04M | 91.96M | 92.08M | 92.53M |
Source: https://incomestatements.info
Category: Stock Reports